D.A. Davidson & CO. Sells 2,697 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

D.A. Davidson & CO. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 41,791 shares of the healthcare conglomerate’s stock after selling 2,697 shares during the quarter. D.A. Davidson & CO.’s holdings in UnitedHealth Group were worth $21,141,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group in the 3rd quarter worth $37,000. DecisionPoint Financial LLC grew its position in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares during the last quarter. Highline Wealth Partners LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $55,000. Finally, Legacy Investment Solutions LLC bought a new position in UnitedHealth Group in the 3rd quarter worth approximately $57,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research reports. Truist Financial dropped their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. KeyCorp restated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Down 1.4 %

Shares of UNH opened at $523.48 on Tuesday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market cap of $481.75 billion, a price-to-earnings ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a fifty day moving average price of $523.11 and a two-hundred day moving average price of $563.00.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the firm posted $5.83 earnings per share. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.